Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02531971 · ClinicalTrials.gov registry record · Phase 4
Fentanyl Patch Pharmacokinetics in Healthy Adults
A Phase 4 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT02531971 is a Phase 4 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 24 participants.
The verdict
NCT02531971, a Phase 4 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The study to be performed will utilize already FDA-approved marketed products in healthy adults for the purpose to generate data for establishing rate of drug delivery comparisons between RLD (reference listed drug) Duragesic ® TDDS (transdermal drug delivery system) and Generic Fentanyl TDDS in healthy adults and to ensure safety of individuals utilizing these types of products.
Interventions
- DRUG Intravenous fentanyl citrate
- DRUG Duragesic®
- DRUG Mylan generic fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-01-14 |
| Est. Completion | 2018-10-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02531971
The ClinicalTrials.gov registry entry for NCT02531971 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Intravenous fentanyl citrate is the first listed.
NCT02531971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02531971 about?
NCT02531971 is a clinical study titled "Fentanyl Patch Pharmacokinetics in Healthy Adults". The study to be performed will utilize already FDA-approved marketed products in healthy adults for the purpose to generate data for establishing rate of drug delivery comparisons between RLD (reference listed drug) Duragesic ® TDDS (transdermal drug delivery system) and Generic Fentanyl TDDS in hea...
What is the current status of trial NCT02531971?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2016-01-14. Estimated completion is 2018-10-16.
What interventions are being tested in trial NCT02531971?
The interventions under investigation include: Intravenous fentanyl citrate (DRUG), Duragesic® (DRUG), Mylan generic fentanyl (DRUG).
Who is sponsoring clinical trial NCT02531971?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.